Cargando…
Fenretinide metabolism in humans and mice: utilizing pharmacological modulation of its metabolic pathway to increase systemic exposure
BACKGROUND AND PURPOSE: High plasma levels of fenretinide [N-(4-hydroxyphenyl)retinamide (4-HPR)] were associated with improved outcome in a phase II clinical trial. Low bioavailability of 4-HPR has been limiting its therapeutic applications. This study characterized metabolism of 4-HPR in humans an...
Autores principales: | Cooper, Jason P, Hwang, Kyunghwa, Singh, Hardeep, Wang, Dong, Reynolds, C Patrick, Curley, Robert W, Williams, Simon C, Maurer, Barry J, Kang, Min H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Science Inc
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144539/ https://www.ncbi.nlm.nih.gov/pubmed/21391977 http://dx.doi.org/10.1111/j.1476-5381.2011.01310.x |
Ejemplares similares
-
Characterization of the metabolism of fenretinide by human liver microsomes, cytochrome P450 enzymes and UDP-glucuronosyltransferases
por: Illingworth, NA, et al.
Publicado: (2011) -
Fenretinide: A Novel Treatment for Endometrial Cancer
por: Mittal, Navdha, et al.
Publicado: (2014) -
The protective effect of fenretinide against allergic asthma
por: Kanagaratham, Cynthia, et al.
Publicado: (2010) -
Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study
por: Kang, Min H, et al.
Publicado: (2014) -
Heterogeneous Role of the Glutathione Antioxidant System in Modulating the Response of ESFT to Fenretinide in Normoxia and Hypoxia
por: Magwere, Tapiwanashe, et al.
Publicado: (2011)